申请人:Lu Qun
公开号:US20140194451A1
公开(公告)日:2014-07-10
Compounds which inhibit the small G protein Rho GTPase cell division cycle protein Cdc42 are provided. Morphological analyses of filopodia, western blots of Ccd42 phosphorylation, and effects on cellular wound healing and on growth cone formation all demonstrate that the described compounds are able to inhibit all tested Cdc42-mediated processes. The compounds effectively inhibit, the effects of Cdc42 and effectively inhibit Cdc42-related cellular functions involving actin, such as Golgi organization and cell movement. Furthermore, the described Cdc42 inhibitor compounds may be provided as a medicament for the treatment of various conditions.
提供了抑制小G蛋白Rho GTP酶细胞分裂周期蛋白Cdc42的化合物。对丝状伪足的形态分析、Ccd42磷酸化的西方印迹、对细胞愈合和生长锥形成的影响均表明,所述化合物能够抑制所有经过测试的Cdc42介导的过程。这些化合物有效地抑制了Cdc42的作用,并有效地抑制了涉及肌动蛋白的Cdc42相关细胞功能,如高尔基体组织和细胞运动。此外,所述的Cdc42抑制剂化合物可以作为治疗各种疾病的药物提供。